189 related articles for article (PubMed ID: 28522287)
1. Patterns of Regional Lymphadenectomy for Clinically Node-negative Patients With Penile Carcinoma: Analysis From the National Cancer Database From 1998 to 2012.
Chipollini J; Tang DH; Sharma P; Baumgarten AS; Spiess PE
Clin Genitourin Cancer; 2017 Dec; 15(6):670-677.e1. PubMed ID: 28522287
[TBL] [Abstract][Full Text] [Related]
2. Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database.
Correa AF; Handorf E; Joshi SS; Geynisman DM; Kutikov A; Chen DY; Uzzo RG; Viterbo R; Greenberg RE; Smaldone MC
J Urol; 2018 May; 199(5):1238-1244. PubMed ID: 29248557
[TBL] [Abstract][Full Text] [Related]
3. Usage and survival implications of surgical staging of inguinal lymph nodes in intermediate- to high-risk, clinical localized penile cancer: A propensity-score matched analysis.
Woldu SL; Ci B; Hutchinson RC; Krabbe LM; Singla N; Passoni NM; Clinton TN; Raj GV; Miller DS; Sagalowsky AI; Lotan Y; Xie Y; Margulis V; Bagrodia A
Urol Oncol; 2018 Apr; 36(4):159.e7-159.e17. PubMed ID: 29288008
[TBL] [Abstract][Full Text] [Related]
4. National Trends and Predictors of Organ-sparing for Invasive Penile Tumors: Expanding the Therapeutic Window.
Chipollini J; Tang DH; Sharma P; Spiess PE
Clin Genitourin Cancer; 2018 Apr; 16(2):e383-e389. PubMed ID: 28967504
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Nodal Upstaging in Clinical Node Negative Patients With Penile Carcinoma: A National Cancer Database Analysis.
Winters BR; Mossanen M; Holt SK; Lin DW; Wright JL
Urology; 2016 Oct; 96():29-34. PubMed ID: 27450944
[TBL] [Abstract][Full Text] [Related]
6. Long-term followup of penile carcinoma with high risk for lymph node invasion treated with inguinal lymphadenectomy.
Marconnet L; Rigaud J; Bouchot O
J Urol; 2010 Jun; 183(6):2227-32. PubMed ID: 20399455
[TBL] [Abstract][Full Text] [Related]
7. Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: results from the Surveillance, Epidemiology, and End Results program.
Johnson TV; Hsiao W; Delman KA; Jani AB; Brawley OW; Master VA
Cancer; 2010 Jun; 116(12):2960-6. PubMed ID: 20564401
[TBL] [Abstract][Full Text] [Related]
8. Contemporary survival trends in penile cancer: Results from the National Cancer Database.
Pham MN; Deal AM; Ferguson JE; Wang Y; Smith AB; Nielsen ME; Pruthi RS; Woods ME
Urol Oncol; 2017 Dec; 35(12):674.e1-674.e9. PubMed ID: 28882672
[TBL] [Abstract][Full Text] [Related]
9. Establishing Criteria for Bilateral Pelvic Lymph Node Dissection in the Management of Penile Cancer: Lessons Learned from an International Multicenter Collaboration.
Zargar-Shoshtari K; Djajadiningrat R; Sharma P; Catanzaro M; Zhu Y; Nicolai N; Horenblas S; Spiess PE
J Urol; 2015 Sep; 194(3):696-701. PubMed ID: 25801766
[TBL] [Abstract][Full Text] [Related]
10. Lessons learnt in the management of primary invasive penile cancer in an Australian tertiary referral centre: clinical outcomes with a minimum 48 months follow-up study.
Chung E; Yang S; White L; Wood S; Nicol D
Korean J Urol; 2015 Feb; 56(2):125-30. PubMed ID: 25685299
[TBL] [Abstract][Full Text] [Related]
11. Is there a benefit to adjuvant radiation in stage III penile cancer after lymph node dissection? Findings from the National Cancer Database.
Winters BR; Kearns JT; Holt SK; Mossanen M; Lin DW; Wright JL
Urol Oncol; 2018 Mar; 36(3):92.e11-92.e16. PubMed ID: 29174944
[TBL] [Abstract][Full Text] [Related]
12. Lymph node yield as a predictor of overall survival following inguinal lymphadenectomy for penile cancer.
Soodana-Prakash N; Koru-Sengul T; Miao F; Lopategui DM; Savio LF; Moore KJ; Johnson TA; Alameddine M; Barboza MP; Parekh DJ; Punnen S; Gonzalgo ML; Ritch CR
Urol Oncol; 2018 Oct; 36(10):471.e19-471.e27. PubMed ID: 30143385
[TBL] [Abstract][Full Text] [Related]
13. Delay to Inguinal Lymph Node Dissection Greater than 3 Months Predicts Poorer Recurrence-Free Survival for Patients with Penile Cancer.
Chipollini J; Tang DH; Gilbert SM; Poch MA; Pow-Sang JM; Sexton WJ; Spiess PE
J Urol; 2017 Dec; 198(6):1346-1352. PubMed ID: 28652123
[TBL] [Abstract][Full Text] [Related]
14. Treatment Trends and Outcomes for Patients With Lymph Node-Positive Cancer of the Penis.
Joshi SS; Handorf E; Strauss D; Correa AF; Kutikov A; Chen DYT; Viterbo R; Greenberg RE; Uzzo RG; Smaldone MC; Geynisman DM
JAMA Oncol; 2018 May; 4(5):643-649. PubMed ID: 29494739
[TBL] [Abstract][Full Text] [Related]
15. Contemporary management of regional nodes in penile cancer-improvement of survival?
Djajadiningrat RS; Graafland NM; van Werkhoven E; Meinhardt W; Bex A; van der Poel HG; van Boven HH; Valdés Olmos RA; Horenblas S
J Urol; 2014 Jan; 191(1):68-73. PubMed ID: 23917166
[TBL] [Abstract][Full Text] [Related]
16. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
[TBL] [Abstract][Full Text] [Related]
17. Stage presentation, care patterns, and treatment outcomes for squamous cell carcinoma of the penis.
Burt LM; Shrieve DC; Tward JD
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):94-100. PubMed ID: 24119832
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic and vascular embolizations are independent predictive variables of inguinal lymph node involvement in patients with squamous cell carcinoma of the penis: Gruppo Uro-Oncologico del Nord Est (Northeast Uro-Oncological Group) Penile Cancer data base data.
Ficarra V; Zattoni F; Cunico SC; Galetti TP; Luciani L; Fandella A; Guazzieri S; Maruzzi D; Sava T; Siracusano S; Pilloni S; Tasca A; Martignoni G; Gardiman M; Tardanico R; Zambolin T; Cisternino A; Artibani W;
Cancer; 2005 Jun; 103(12):2507-16. PubMed ID: 15856474
[TBL] [Abstract][Full Text] [Related]
19. Lymph node metastasis in intermediate-risk penile squamous cell cancer: a two-centre experience.
Hughes BE; Leijte JA; Kroon BK; Shabbir MA; Swallow TW; Heenan SD; Corbishley CM; van Boven HH; Perry MJ; Watkin NA; Horenblas S
Eur Urol; 2010 Apr; 57(4):688-92. PubMed ID: 19647926
[TBL] [Abstract][Full Text] [Related]
20. The appropriate number of negative lymph nodes dissection for nonmetastatic penile cancer.
Wei Z; Yu Z; Li H; Peng W; Zhang J; Zhang Y; Song W; Liu J; Yang W; Wang T
Andrologia; 2019 Feb; 51(1):e13154. PubMed ID: 30255596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
